Scientific Program

Scientific Abstracts were presented in three formats at the 22nd ASBrS Annual Meeting:

• Oral—Oral Presentations were held during the Scientific Session on Friday, April 30, and Sunday, May 2, 2021.

• Quickshot—Quickshot Presentations were be held on Saturday, May 1, 2021.

• Poster—Virtual Poster Sessions were held on Thursday, April 29, and Saturday, May 1, 2021.

1. Cryoablation Without Excision for Early-Stage Breast Cancer; ICE3 Trial Update on Ipsilateral Breast Tumor Recurrence

   • Richard Fine, MD
     West Cancer Center & Research Institute, Germantown, TN USA

2. Routine Perioperative and Post-Discharge Use of Non-Steroidal Anti-Inflammatory Drugs: What is the Risk of Hematoma after Lumpectomy and Sentinel Lymph Node Biopsy?

   • Kate Pawloski, MD
     Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY USA

3. Contralateral Axillary Nodal Metastases: Stage IV Disease or a Manifestation of Progressive Locally Advanced Breast Cancer?

   • Amanda Nash, MD
     Duke University Medical Center, Durham, NC USA

4. Ongoing Symptoms Experienced by Low Risk Breast Cancer Survivors Following Active Treatment

   • Jessica Schumacher, PhD, MS
     University of Wisconsin-Madison, Madison, WI USA

5. Improvement in Breast Reconstruction Disparities Following Medicaid Expansion Under the Affordable Care Act

   • Kirithiga Ramalingam, MD
     Loma Linda University Health, Loma Linda, CA USA

1. Cutting Instruments to Cut Costs: A Simple Initiative with Breast Surgical OR Trays that Resulted in Substantial Savings

   • Jandie Schwartz, DO
     University of Pittsburgh, Magee Women's Hospital, Pittsburgh, PA USA

2. Nipple Sparing Mastectomy: Are We Providing Proper Prophylactic Antibiotic Coverage?

   • Ayat ElSherif, MD
     Cleveland Clinic, Cleveland, OH USA

3. Clinical Course of Breast Cancer Patients with Local Regional Progression during Neoadjuvant Systemic Therapy

   • Leisha Elmore, MD, MPHS
     The University of Texas MD Anderson Cancer Center, Houston, TX USA

4. High Resolution Full 3D Specimen Imaging for Lumpectomy Margin Assessment

   • Swati Kulkarni, MD
     Department of Surgery, Northwestern University, Chicago, IL

5. Analysis of the impact of the COVID-19 pandemic on the multidisciplinary management of breast cancer: Review from the first 8 months of the American Society of Breast Surgeons COVID and Mastery registries.

   • Lee Wilke, MD
     University of Wisconsin School of Medicine and Public Health, Madison, WI USA

1. Controversial Areas in Axillary Staging: Are we following the guidelines?

   • Ava Armani, MD
     UCSD, San Diego, CA USA

2. A Survey of the American Society of Breast Surgeons Membership on Contemporary Axillary Management in Mastectomy Patients

   • Chandler Cortina, MD
     Medical College of Wisconsin, Milwaukee, WI USA

3. Objective Assessment of Post-Operative Morbidity following Breast Cancer Treatments with Wearable Activity Monitors - The BRACELET study

   • Nur Amalina Che Bakri, MD
     Imperial College London, United Kingdom

4. Correlation of gene-expression from the 21-gene recurrence score between core biopsy and surgical specimen in patients with breast cancer

   • Javier Orozco, MD
     John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA USA

5. Apocrine Breast Cancer: Unique Features of a Predominantly Triple Negative Cancer

   • Angeleke Saridakis, MD
     Yale, New Haven, CT USA

6. Guiding Light to Optimize Wide Local Excisions: The "GLOW" Study.

   • Maria Leiloglou, MSc
     Imperial College London, United Kingdom

7. The relationship between breast and axillary pathologic complete response in women receiving neoadjuvant chemotherapy for breast cancer.

   • David Lim, MDCM, MEd, PhD
     Women's College Research Institute, Women's College Hospital, Toronto, Ontario Canada

1. The Risk of Contralateral Breast Cancer: A SEER-based Analysis.

   • David Lim, MDCM, MEd, PhD
     Women's College Research Institute, Women's College Hospital, Toronto, Ontario Canada

2. High-Risk Breast Lesions Found on Core Needle Biopsy: Which Ones to Excise?

   • Quynh Le, DO
     Hoag Memorial Hospital, Newport Beach, CA USA

3. Neoadjuvant endocrine therapy and delays in surgery for ductal carcinoma in situ: implications for the coronavirus pandemic

   • Austin Williams, MD, MSEd
     Lankenau Medical Center, Wynnewood, PA USA

4. Improving the breast surgeon’s ergonomic workload for nipple-sparing mastectomies using exercise and an operating room positioning protocol

   • Amanda Deliere, MD
     NorthShore University Health System, Evanston, IL USA

5. The Emerging Role of Telehealth in Preoperative Evaluation of Breast Cancer Patients During the COVID-19 Pandemic

   • Annie Tang, MD
     University of California San Francisco, East Bay, Oakland, CA USA

1. Invasive Lobular Breast Cancer: Data to Guide Surgical Decision Making

   • Daniela Cocco, MD
     Cleveland Clinic, Cleveland, OH USA

2. Two-stage versus One-stage Nipple Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss

   • Tammy Ju, MD
     Stanford University School of Medicine, Stanford, CA USA

3. The effect of age on outcomes after neoadjuvant chemotherapy for breast cancer

   • Francys Verdial, MD
     Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY USA

4. RNA-seq and Tumor Infiltrating Lymphocytes as Markers of Tumor Microenvironment Changes after Cryoablation

   • Sonia Khan
     Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center Lubbock, TX USA

5. Multidisciplinary management of intraductal papilloma of the breast can identify patients safely managed without surgical excision

   • Shahrzad Abbassi-Rahbar, MD
     University of Kansas Medical Center, Kansas City, KS USA

Questions?

Email: abstracts@breastsurgeons.org
Phone: 410‑381‑9500 or 877‑992‑5470 (M—F 8:30 am–5:00 pm et)